Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.077 | 0.2 |